These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9852398)

  • 1. Endocrine therapy in pancreatic carcinoma.
    Yamashita J; Abe M; Ogawa M
    Oncology; 1998 Dec; 55 Suppl 1():17-22. PubMed ID: 9852398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-type plasminogen activator predicts endocrine responsiveness of human pancreatic carcinoma cells.
    Kuramoto M; Yamashita J; Ogawa M
    Cancer; 1995 Mar; 75(6):1263-72. PubMed ID: 7882277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medroxyprogesterone acetate inhibits human pancreatic carcinoma cell growth by inducing apoptosis in association with Bcl-2 phosphorylation.
    Abe M; Yamashita J; Ogawa M
    Cancer; 2000 May; 88(9):2000-9. PubMed ID: 10813710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-steroid hormones for uterine cancer].
    Komiyama S; Nishio E; Yasue A; Hasegawa K; Udagawa Y
    Nihon Rinsho; 2008 Jan; 66(1):174-81. PubMed ID: 18186261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormone therapy of endometrial carcinoma].
    Kuramoto H; Jobo T; Kato Y; Tateoka K; Sato R
    Gan To Kagaku Ryoho; 1996 May; 23(6):673-7. PubMed ID: 8645016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New developments in hormonal therapy for breast cancer].
    Tominaga T
    Gan To Kagaku Ryoho; 1996 May; 23(6):678-83. PubMed ID: 8645017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selecting adjuvant endocrine therapy for breast cancer.
    Eneman JD; Wood ME; Muss HB
    Oncology (Williston Park); 2004 Dec; 18(14):1733-44, discussion 1744-5, 1748, 1751-4. PubMed ID: 15700624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Navigating the Challenges of Endocrine Treatments in Premenopausal Women with ER-Positive Early Breast Cancer.
    Colleoni M; Munzone E
    Drugs; 2015 Aug; 75(12):1311-21. PubMed ID: 26177891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in hormonal therapy for cancer.
    Traynor A
    Curr Opin Oncol; 1995 Nov; 7(6):572-81. PubMed ID: 8547408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-dependent tumors. Overview.
    Ogata E
    Oncology; 1998 Dec; 55 Suppl 1():3-4. PubMed ID: 9935360
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tamoxifen and breast cancer: is everything known already?].
    Marchetti P; Porzio G; Trapasso T; Baldi PL; Ficorella C
    Tumori; 1998; 84(6):A1-5. PubMed ID: 10080686
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of prognostic factors and comparison of systemic treatment modalities in patients with recurrent or metastatic endometrial carcinoma.
    Karagol H; Saip P; Uygun K; Kucucuk S; Aydiner A; Topuz E
    Med Oncol; 2006; 23(4):543-8. PubMed ID: 17303913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer.
    De Marchi T; Foekens JA; Umar A; Martens JW
    Drug Discov Today; 2016 Jul; 21(7):1181-8. PubMed ID: 27233379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the treatment of endocrine responsive metastatic breast cancer in postmenopausal women.
    Cardoso F; Bischoff J; Brain E; Zotano ÁG; Lück HJ; Tjan-Heijnen VC; Tanner M; Aapro M
    Cancer Treat Rev; 2013 Aug; 39(5):457-65. PubMed ID: 22840697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Action of SERM and SAS (tibolone) on breast tissue].
    Gompel A; Jacob D; de Chambine S; Mimoun M; Decroix Y; Rostene W; Poitout P
    Contracept Fertil Sex; 1999 May; 27(5):368-75. PubMed ID: 10401183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent problems on the endocrine and chemotherapy].
    Nishiya I; Yoshizaki A; Satoh K; Matsuta M; Fukushima A
    Hum Cell; 1995 Sep; 8(3):107-14. PubMed ID: 8652446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Strategy of drug development for hormone-dependent tumor].
    Kudoh M
    Gan To Kagaku Ryoho; 1996 May; 23(6):668-72. PubMed ID: 8645015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitor induced modulation of anti-estrogen therapy.
    Thomas S; Munster PN
    Cancer Lett; 2009 Aug; 280(2):184-91. PubMed ID: 19185986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal treatment of endometrial carcinoma.
    Baekelandt M
    Expert Rev Anticancer Ther; 2002 Feb; 2(1):106-12. PubMed ID: 12113059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiestrogen therapy of patients with uterine cancer].
    Sugimura M; Terao T
    Nihon Rinsho; 1994 Mar; 52(3):804-8. PubMed ID: 8164386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.